BHC
NYSE · Pharmaceuticals
Bausch Health Cos Inc
$5.75
+0.02 (+0.35%)
Performance
1D
—
1W
—
1M
—
3M
-3.85%
6M
-15.57%
1Y
+20.29%
YTD
-20.25%
Open$5.70
Previous Close$5.73
Day High$5.80
Day Low$5.64
52W High$11.97
52W Low$6.06
Volume—
Avg Volume494.7K
Market Cap2.92B
P/E Ratio—
EPS$-3.24
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$6.64
Below
SMA 200
$6.36
Below
RSI (14)
60
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Sell
9 analysts
Price Target
+1,704.9% upside
Current
$5.75
$5.75
Target
$103.78
$103.78
$65.08
$103.78 avg
$115.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 13.91B | 12.86B | 415.01M |
| Net Income | 212.67M | 177.04M | 120.28M |
| Profit Margin | 1.5% | 1.5% | 29.0% |
| EBITDA | 4.03B | 3.54B | 156.90M |
| Free Cash Flow | — | — | 115.51M |
| Rev Growth | +8.1% | +8.1% | +10.0% |
| Debt/Equity | 44.72 | 44.72 | 0.48 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |